GSK/UW Summer Symposium 2024

This event has passed.

UW–Madison, Department of Chemistry Seminar Hall, 1315

INFORMATION

Keynote Speaker – Prof Richmond Sarpong (UC Berkeley)

Prof. Sarpong’s laboratory focuses on the synthesis of bioactive complex organic molecules, with a particular focus on secondary metabolites that come from marine or terrestrial flora and fauna. These natural products continue to serve as the inspiration for new medicines

Industrial Speakers – Mark Mantell: Scientist at GSK- DNA Encoded Technology and Philip Clayman: Investigator at GSK – Enzyme Engineering and Biocatalysis

Student/Postdoc Flash Presentations. Sign up here for the Career Panel, Networking Lunch, and Poster Sessions.

===========================================================

SCHEDULE

9 – 10 a.m. Career Panel with GSK Scientists

RM 2401 (Coffee and Greenbush donuts provided)

10 – 10:30 a.m. Coffee & donuts

Outside Seminar Hall

10:30 a.m. Symposium Introduction

Seminar Hall

10:45 a.m. – 12:30 p.m. UW Flash Talks (details below)

Katie Weber (Yoon Group)

Y Dang (Wickens Group)

Dr. Xianyuan Zhao (Yang Group)

Irene Stoutland (Blackwell Group)

Christopher Hanneman (Stahl Group)

Lauren Ehehalt (Weix Group)

12:30 – 2 p.m. Networking Lunch (food provided)

                Learning Studio (1435 North Tower)

2 – 3:20 p.m. GSK Presentations (details below)

Dr. Mark Mantell (DNA Encoded Technology)

Dr. Philip Clayman (Enzyme Engineering & Biocatalysis)

3:30 – 5 p.m. Keynote Speaker (details below)

Prof. Richmond Sarpong

5 – 6:30 p.m. Poster Session – Drinks and light snacks provided

North Tower Atrium

===========================================================

DETAILS

Flash Presentations

Name: Katie Weber
Research Group: Yoon

Title: Visible Light-Promoted Direct Lactonization Enabled By 1,5–Hydrogen Atom Transfer


Abstract: Photoinduced ligand-to-metal charge transfer (LMCT) has been of interest to synthetic chemists for a variety of transformations. Moreover, base metals such as copper and iron have been widely employed to promote decarboxylation of a variety of carboxylic acids. Carboxy radicals are known to undergo other modes of reactivity, such as hydrogen atom transfer (HAT), however, these methods typically require the use of toxic hypervalent iodine catalysts or employ expensive photoredox catalysts. Herein, we report the first use of LMCT to generate a carboxy radical which is used to promote HAT. The synthesis of a variety of different lactones derives from benzoic acids and aliphatic carboxylic acids is shown. Finally, the reaction mechanism with regards to the nature of the HAT step is explored.

—————————————————————————————-

Name: Y Dang
Research Group: Wickens Group

Title: Formate-enabled Alkene Carboxylation-Alkylation via Radical Polar Crossover


Abstract: Herein, we introduced an alkene carboxylation-alkylation platform with abundant carbonyls and formate salts via radical polar crossover. This work leveraged the photoactivation of formate to generate CO2•– under exceptionally mild conditions that can prevent the competitive reduction of carbogenic electrophiles. The optimized photocatalytic system successfully promoted alkene carboxylation-alkylation across different π-systems and diverse carbonyl electrophiles (aldehydes, ketones). Alkenyl arenes with varying electronic and steric profiles were productively coupled in the reaction, generating a diverse array of multi-substituted -lactone products. Furthermore, indoles can also participate in a dearomative carboxylation-alkylation reaction, delivering several medicinally relevant sp3-rich heterocyclic scaffolds. Mechanistic investigation revealed a distinct induction period for the desired product formation. Through UV-vis studies, we found that the photocatalyst activation pathway was responsible for this observed induction period. Overall, we have developed a three-component alkene carboxylation-alkylation reaction enabled by the use of formate as the CO2•– precursor.

—————————————————————————————-

Name: Dr. Xianyuan Zhao
Research Group: Yang

Title: Investigating proton transfer wire in human transketolase for an explanation of its cooperativity

Abstract: The hybrid quantum mechanics/molecular mechanics (QM/MM) approach, which combines the accuracy of quantum mechanical (QM) methods with the efficiency of molecular mechanics (MM) methods, is widely used in the study of complex systems. However, past QM/MM implementations often neglect or face challenges in addressing nuclear quantum effects, despite their crucial role in many key chemical and biological processes. Recently, our group developed the constrained nuclear-electronic orbital (CNEO) theory, a cost-efficient approach that accurately addresses nuclear quantum effects, especially quantum nuclear delocalization effects. In this work, we integrate CNEO with the QM/MM approach through the electrostatic embedding scheme and apply the resulting CNEO QM/MM to two hydrogen-bonded complexes in both gas and aqueous phases. We find that both solvation effects and nuclear quantum effects significantly impact hydrogen bond structures and dynamics. Notably, in the glutamic acid – glutamate complex, which mimics a low barrier hydrogen bond in human transketolase, CNEO QM/MM accurately predicts nearly equal proton sharing between the two residues. With an accurate description of both quantum nuclear delocalization effects and environmental effects, CNEO QM/MM is a promising new approach for simulating complex chemical and biological systems.

—————————————————————————————-

Name: Irene Stoutland
Research Group: Blackwell

Title: Investigations into the structural determinants of associative and dissociative mechanisms in LuxR-type quorum sensing receptors

Abstract: LuxR/I-type quorum sensing (QS) regulates a variety of cell density-dependent phenotypes, including biofilm formation, virulence, and symbiosis, in many common species of Gram-negative bacteria. Small molecules that target QS are of interest as chemical probes to better understand QS systems and for potential applications in antivirulence, antibiofouling, and synthetic biology. To this end, the Blackwell research lab has developed a variety of small molecule agonists and antagonists targeting LuxR-type QS receptors. These intracellular receptors are transcription factors that are activated by binding to small molecule autoinducer ligands. The general lack of information about LuxR receptor structure and the precise mechanisms of action of small molecule LuxR modulators, antagonists in particular, is a significant barrier to the design of more potent, specific, and stable probes. The current study aims to determine the structural features that differentiate LuxR receptors that are most active in the presence of ligand (associative) and those that are most active in the absence of ligand (dissociative). Through the design and generation of “chimeric” LuxRs combining domains from the associative LasR receptor of Pseudomonas aeruginosa, the dissociative EsaR receptor of Pantoea stewartii, and/or the dissociative ExpR2 receptor of Pectobacterium versatile, we have found that the ligand-binding domain, rather than the DNA-binding domain, determines whether a LuxR-type receptor is more active in the presence of ligand or in its absence. Select synthetic LasR antagonists were found to maintain their activity in chimeras with interchanged, dissociative-type DNA-binding domains. In addition, a complementary mutagenesis approach revealed that LasR, EsaR, and ExpR2 have divergent responses to changes in the length of the linker region between the ligand-binding and DNA-binding domains, which has broader implications for our understanding of signal transduction in general in this class of receptors. Collectively, these results provide a deeper understanding of the modes by which small molecules control the activity of mechanistically distinct LuxR-type receptors and suggests new routes for the manipulation of LuxR/I-type QS network.

—————————————————————————————-

Name: Christopher M. Hanneman
Research Group: Stahl

Title: Copper-Nitroxyl Catalyzed α-Oxygenation of Cyclic Secondary Amines


Abstract: Cyclic secondary amines are prominent subunits in pharmaceutical compounds. Methods for direct functionalization of N-unprotected/unsubstituted piperidines and related heterocycles have limited precedent despite their potential to impact medicinal chemistry and organic synthesis. Herein, we report a Cu/nitroxyl co-catalyzed method for direct conversion of cyclic secondary amines to the corresponding lactams via aerobic dehydrogenation and oxidative coupling with water. The mild reaction conditions tolerate diverse functional groups, enabling application to molecules that cover broad chemical space. The method is showcased in selective functionalization of building blocks and complex molecules, including late-stage functionalization of bromodomain inhibitors.

—————————————————————————————-

Name: Lauren Ehehalt
Research Group: Weix

Title: Using Metal-Organic Frameworks as Efficient Carbon Monoxide Removal Reagents in Decarbonylative Cross-Electrophile Coupling

Abstract: Current methods of decarbonylative cross-couplings rely on elevated temperatures or near-stoichiometric equivalences of precious metal salt additives to promote decarbonylation. However, these methods pose problems in scale-up, both from a cost and safety perspective. There exists, then, a need for a safe, recyclable reagent to promote decarbonylation at more mild temperatures. We report the use of a nickel-based Metal Organic Framework (MOF) as an efficient CO removal reagent and highlight its utility in decarbonylative cross-electrophile couplings. By using an In-Ex Tube and Phosphonium Ionic Liquid, the MOF remains separated from the reaction mixture, allowing for immediate transfer and reuse in subsequent reactions. Through experimental data and DFT calculations, the high binding affinity of CO(g) to the MOF is notable, providing further insights into its utility.

===========================================================

GSK Presentations

Speaker: Dr. Mark Mantell, Scientist at GSK- DNA Encoded Technology

Title: DNA-compatible Ugi 4C-3C Reactions

Abstract: Developing new on-DNA reactions is paramount to the development of new encoded libraries in the pursuit of novel pharmaceutical lead compounds. Lactam-containing molecules have been shown to be effective in a wide range of therapeutic areas and therefore represent a promising target for further investigation by DNA-encoded library screening. In pursuit of this motif, we report a novel method for the introduction of lactam-containing structures onto a DNA headpiece through the Ugi four-center three-component reaction (4C-3CR). This novel method is successful in three different approaches to give unique on-DNA lactam structures: on-DNA aldehyde coupled with isonitriles and amino acids; on-DNA isonitrile coupled with aldehydes and amino acids; and on-DNA isonitrile coupled with amines and acid aldehydes.

—————————————————————————————-

Speaker: Dr. Philip Clayman, Investigator at GSK – Enzyme Engineering and Biocatalysis

Title: Enabling Drug Discovery and Development with Biocatalysis

===========================================================

Keynote

Speaker: Dr. Richmond Sarpong, Department of Chemistry, University of California–Berkeley

Title: Break-it-to-Make-it Strategies for Chemical Synthesis Inspired by Complex Natural Products

Abstract: Natural products continue to inspire and serve as the basis of new medicines. They also provide intricate problems that expose limitations in the strategies and methods employed in chemical synthesis. Several strategies and methods that have been developed in our laboratory and applied to the syntheses of architecturally complex natural products will be discussed. In particular, new ways to employ the cleavage of core bonds such as C–C and C–N bonds (i.e., break-it-to-make-it strategies) to achieve skeletal editing will be presented.

[1] Marth, C.J.; Gallego, G.M.; Lee, J.C.; Lebold, T.P.; Kulyk, S.; Kou, K.G.M.; Qin, J.; Lilien, R.; Sarpong, R.; Nature 2015, 528, 493.
[2] Mercado-Marin, E.V.; Garcia-Reynaga, P.; Romminger, S.; Pimenta, E.F.; Romney, D.K.; Lodewyk, M.W.; Williams, D.E.; Andersen, R.J.; Miller, S.J.; Tantillo, D.J.; Berlinck, R.G.S.; Sarpong, R.; Nature 2014, 509, 318.
[3] Roque, J. B.; Kuroda, Y.; Göttemann, L. T.; Sarpong, R. Science, 2018, 361, 171.
[4] Roque, J. B.; Kuroda, Y.; Göttemann, L. T.; Sarpong, R. Nature, 2018, 564, 244.
[5] Jurczyk, J.; Lux, M. C.; Adpressa, D.; Kim, S.F.; Lam, Y.; Yeung, C. S.; Sarpong, R. Science 2021, 373, 1004.